Keck Hospital of USC.
Children's Hospital Los Angeles, Los Angeles, California, USA.
Curr Opin Organ Transplant. 2021 Aug 1;26(4):356-359. doi: 10.1097/MOT.0000000000000898.
Pediatric kidney transplantation is the definitive therapy for infants and children suffering from renal failure. It is a distinct endeavor demanding specialized care for optimal results. This includes a dedicated preoperative workup accounting for unique predisposing urologic conditions, specialized surgical techniques, and careful hemodynamic monitoring and maintenance.
Historically, size-matched renal allografts from pediatric donors to pediatric recipients suffered from poor outcomes. Advances in surgical technique performed at high volume centers have shown that these operations can be performed safely, helping expand the donor pool for these patients. Concurrently, transplantation of increasingly small for size infants with complex medical and surgical backgrounds has become a reality.
On a policy front, efforts to expand access to size-matched organs, combined with advances in medical management and immunosuppression have seen pediatric renal transplantation reach new heights. Now, these breakthroughs are heightened by the ability to transplant such organs into the smallest infants. The net result will be diminished transplant waiting times and, accordingly, improved quality of life and longevity for children suffering from renal failure.
儿科肾移植是治疗肾衰竭婴儿和儿童的确定性疗法。这是一项独特的努力,需要专门的护理以达到最佳效果。这包括专门的术前检查,考虑到独特的易患泌尿科疾病、专门的手术技术以及仔细的血液动力学监测和维持。
从历史上看,来自儿科供体的与儿童受者匹配大小的肾移植物的结果不佳。在高容量中心进行的手术技术的进步表明,这些手术可以安全进行,有助于扩大这些患者的供体库。同时,对具有复杂医疗和外科背景的越来越小的供体婴儿进行移植已成为现实。
在政策方面,扩大匹配大小器官的机会的努力,加上医疗管理和免疫抑制方面的进步,使得儿科肾移植达到了新的高度。现在,这些突破的特点是能够将这些器官移植到最小的婴儿体内。最终结果将是减少移植等待时间,从而提高患有肾衰竭的儿童的生活质量和寿命。